HEPATIC CANDIDIASIS

HEPATIC CANDIDIASIS was reported 68 times

HEPATIC CANDIDIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 6 0.0007
1 Anthracycline Topoisomerase Inhibitor [EPC] 1 0.0004
2 CD33-directed Immunoconjugate [EPC] 1 0.0003
3 Lipid-based Polyene Antifungal [EPC] 3 0.0002
4 Topoisomerase Inhibitor [EPC] 16 0.0002
5 Azole Antifungal [EPC] 15 0.0001
6 Aminoglycoside Antibacterial [EPC] 4 0.0001
7 Purine Antimetabolite [EPC] 8 0.0001
8 BCL-2 Inhibitor [EPC] 5 0.0001
9 Asparagine-specific Enzyme [EPC] 1 0.0001
10 Polyene Antifungal [EPC] 3 0.0001
11 Provitamin D2 Compound [EPC] 2 0.0001
12 Platinum-based Drug [EPC] 18 0.0001
13 Alkylating Drug [EPC] 16 0.0001
14 Penem Antibacterial [EPC] 2 0.0001
15 Nucleoside Metabolic Inhibitor [EPC] 16 0.0001
16 Fluoroquinolone Antibacterial [EPC] 6 0.0000
17 Nitroimidazole Antimicrobial [EPC] 3 0.0000
18 Histamine-1 Receptor Antagonist [EPC] 3 0.0000
19 Leukocyte Growth Factor [EPC] 5 0.0000
20 Iron Chelator [EPC] 1 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
23 Corticosteroid [EPC] 20 0.0000
24 Glycopeptide Antibacterial [EPC] 1 0.0000
25 Integrin Receptor Antagonist [EPC] 1 0.0000
26 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
27 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
28 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
29 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
30 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
31 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
32 Calcium [EPC] 1 0.0000
33 Microtubule Inhibitor [EPC] 1 0.0000
34 Benzodiazepine [EPC] 4 0.0000
35 Opioid Agonist [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 2 0.0000
37 Loop Diuretic [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000